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Abstract
 
Malaria starts with 
 
Plasmodium
 
 sporozoites infection of the host’s liver, where development into
blood stage parasites occurs. It is not clear why natural infections do not induce protection
against the initial liver stage and generate low CD8
 
  
 
T cell responses. Using a rodent malaria
model, we show that 
 
Plasmodium
 
 blood stage infection suppresses CD8
 
  
 
T cell immune re-
sponses that were induced against the initial liver stage. Blood stage 
 
Plasmodium
 
 affects dendritic
cell (DC) functions, inhibiting maturation and the capacity to initiate immune responses and
inverting the interleukin (IL)-12/IL-10 secretion pattern. The interaction of blood stage para-
sites with DCs induces the secretion of soluble factors that inhibit the activation of CD8
 
  
 
T
cells in vitro and the suppression of protective CD8
 
  
 
T cell responses against the liver stage in
vivo. We propose that blood stage infection induces DCs to suppress CD8
 
  
 
T cell responses in
natural malaria infections. This evasion mechanism leaves the host unprotected against reinfec-
tion by inhibiting the immune response against the initial liver stage of the disease.
Key words:
 
Plasmodium yoelii
 
 • sporozoites • CD8
 
  
 
T cells • erythrocytes
 
Introduction
 
Malaria is transmitted through the bite of an infected mos-
quito, which introduces 
 
Plasmodium
 
 sporozoites into the
mammalian host. Sporozoites rapidly reach the liver of
the host where they develop and replicate into merozoites,
the parasitic stage that infects erythrocytes and causes the
pathology of the disease. It is unclear why natural infections
do not induce protection against the initial liver stage of
 
Plasmodium
 
 and generate only low cytotoxic CD8
 
  
 
T cell
responses (1–3). In endemic areas, this lack of protection
against liver stage infection results in constant malaria rein-
fections throughout life (2). Despite the lack of protection
induced against the liver stage of the disease, the feasibility
of vaccination was proven by immunization of mice and
humans with irradiated 
 
Plasmodium
 
 sporozoites that induce
protection against this stage of the parasite (4, 5). Protec-
tion is mediated by high CD8
 
  
 
T cell responses specific
against infected hepatocytes (6).
 
Plasmodium
 
 is extremely well-adapted to its hosts. In hu-
mans, a malaria infection can be established by as few as 10
sporozoites (7). Another important factor in the success of
this parasite is its ability to evade the host immune response
by antigenic diversity, clonal antigenic variation, and T cell
antagonism (8–10). In addition to these evasion mecha-
 
nisms, the existence of malaria-induced immune suppression
is suggested by the association of malaria with a higher inci-
 
dence of other infectious diseases (11–13) and reduced
immune responses to vaccination during malaria infections
(14, 15). Impaired cell-mediated immunity in patients with
acute blood stage malaria infections (16–18) and altered
macrophage responses (19–22) have also been associated
with malaria-induced immune suppression.
 
Dendritic cells (DCs)
 
*
 
 are antigen-presenting cells that
play a central role in both innate and adaptive immune re-
sponses. Immature DCs uptake and process antigens in the
peripheral areas of the body. After detecting microbial prod-
ucts or proinflammatory cytokines, DCs mature and migrate
to lymphoid organs to initiate immune responses (23). Mat-
uration of DCs augments their antigen presentation capacity,
as peptide loading, half-life, and delivery of MHC molecules
to the cell surface are increased, as well as surface expression
of T cell costimulatory molecules (23). Several pathogens in-
terfere with the host immune response by targeting different
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Abbreviations used in this paper:
 
 CFDA SE, succinimidyl ester; CS, cir-
cumsporozoite; DC, dendritic cell.T
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functions of DCs, including the maturation and migration of
these cells (24). In particular, 
 
Plasmodium falciparum
 
–infected
erythrocytes modulate the maturation of DCs and their ca-
pacity to activate T cells in vitro (25), suggesting a role for
DCs in malaria-induced immune suppression.
Here, we show that 
 
Plasmodium
 
 blood stage infection
suppresses CD8
 
  
 
T cell responses against the liver stage of
the parasite. In this way, the blood stage infection inhibits
the establishment of a protective response against the initial
liver stage, leaving the host susceptible for the next infec-
tion. Our results provide an explanation for the lack of
liver stage immunity that occurs in malaria and that is criti-
cal for the prevalence of this disease. We also found that
 
Plasmodium
 
 blood stage infection affects DCs maturation,
cytokine secretion, and the capacity to initiate new im-
mune responses. After interaction with infected erythro-
cytes, DCs also acquire the capacity to suppress CD8
 
  
 
T
cell responses in immunized mice. The incubation of in-
fected erythrocytes with DCs induces the secretion of solu-
ble factors that inhibit T cell activation. This mechanism
probably plays an important role the suppression of liver
stage immunity observed in malaria infections.
 
Materials and Methods
 
Parasites and Mice. Plasmodium yoelii
 
 (nonlethal parasite line 17
XNL) sporozoites were obtained from the dissection of infected
 
Anopheles stephensi
 
 mosquito salivary glands. BALB/c mice (hap-
lotype 
 
H-2K
 
d
 
) were purchased from Taconic.
 
Immunization, Erythrocytes Isolation, Challenge with Sporozoites,
and Artemisinin Treatment.
 
Mice immunization was performed
by intravenous injection of 10
 
5 
 
radiation-attenuated sporozoites
(
 
  
 
source, 20 Krad). 
 
P. yoelii
 
–infected erythrocytes used for in-
duction of malaria blood stage were obtained from infected Swiss
Webster mice with 
 
 
 
25% parasitemia. 
 
P. yoelii
 
–infected erythro-
cytes were washed three times with PBS and separated from
white blood cells by centrifugation at 2,000 
 
g
 
. To induce blood
stage infection, 4 
 
  
 
10
 
6 
 
P. yoelii
 
–infected erythrocytes were in-
jected intravenously into each mouse.
Challenge of mice was performed in groups of three mice by
intravenous injection of 10
 
5 
 
nonirradiated 
 
P. yoelii
 
 sporozoites.
Real-time PCR using primers for 
 
Plasmodium
 
 18s rRNA was
used for quantification of parasite load in the livers of mice 44 h
after challenge (26).
Groups of three mice were treated for 10 d with 50 mg/kg/
day of artemisinin diluted in DMSO. Treatment started 1 d after
infection with 10
 
5 
 
sporozoites. Groups of control mice received
the same volume of DMSO.
 
ELISPOT Assay and CD8
 
  
 
T Cell Proliferation.
 
With spleen
cells, determination of individual IFN-
 
 
 
–secreting T cells specific
for the 
 
H-2K
 
d 
 
CD8 epitope of the circumsporozoite (CS) protein
SYVPSAEQI of 
 
P. yoelii
 
 was done by ELISPOT (27). T cells
were enriched from spleen suspensions by the elimination of plas-
tic adherent and IgG- and IgM-reactive cells. 1.5 
 
  
 
10
 
5 
 
A20.2J
cells preincubated with a peptide spanning the CD8 epitope were
used as antigen-presenting cells for enriched T cell suspensions.
The numbers of antigen-specific T cells are calculated by sub-
tracting the mean spot numbers in duplicate control wells where
enriched T cells are incubated with A20.2J cells without peptide.
With CD8
 
  
 
T cell clone (provided by F. Zavala, New York Uni-
versity, New York, NY), 10
 
5 
 
A20.2J cells or bone marrow–
 
derived DCs preincubated with uninfected or 
 
P. yoelii
 
–infected
erythrocytes and maturated as described below were pulsed with
the specific CD8 epitope or infected with 10
 
6 
 
PFU recombinant
influenza virus expressing the same CD8 epitope (provided by A.
Garcia-Sastre, Mount Sinai, New York, NY; reference 28). The
pulsed or infected DCs were incubated with 100 or 300 cells per
well of the CD8
 
  
 
T cell clone (29), which is specific for SYVP-
SAEQI epitope. The numbers of antigen-specific CD8
 
  
 
T cell
clone cells are calculated by subtracting the mean spot numbers in
duplicate control wells where CD8
 
  
 
T cell clone cells are incu-
bated with A20.2J cells without peptide or virus. To test whether
sporozoites would inhibit the activation of T cells by DCs, sporo-
zoites and DCs were preincubated for 24 h at a ratio of 10:1 be-
fore pulsing DCs with the specific CD8 epitope and the addition
of CD8
 
  
 
T cell clone. The incubation media of DCs and unin-
fected erythrocytes or 
 
P. yoelii
 
–infected erythrocytes for 48 h
were added to 10
 
5 
 
DCs or 10
 
5 
 
A20.2J cells loaded with the pep-
tide spanning the CS epitope before the addition of CD8
 
  
 
T cell
clone cells. Pulsed DCs were also incubated with CD8
 
  
 
T cell
clone in the presence of 25 ng/ml of recombinant mouse IL-12
or 50 
 
 
 
g/ml of anti–mouse IL-10 monoclonal antibody (JES5-
16E3; BD Biosciences). The concentrations of recombinant IL-
12 and anti–IL-10 antibodies are at least 10
 
3 
 
times greater than
the concentration of these cytokines in the supernatant of DCs
with LPS. The proliferation of antigen-activated CD8
 
  
 
T cell
clone cells was measured using succinimidyl ester (CFDA SE)
staining (Molecular Probes) with carboxyfluorescein diacetate.
10
 
5 
 
CFDA SE-stained CD8
 
  
 
T cell clone cells were mixed with
10
 
6 
 
DCs pulsed with the CD8 epitope and preincubated with un-
infected or 
 
P. yoelii
 
–infected erythrocytes. After 5 d CFDA SE
fluorescence was analyzed by FACS
 
®
 
.
 
Preparation of DCs from Mouse Bone Marrow and Incubation with
P. yoelii–infected Erythrocytes.
 
Primary cultures of immature DCs
from BALB/c mice were obtained by differentiation of bone mar-
row–derived precursors for 10 d (30) using the supernatant of the
myeloma cell line Ag8653 expressing mouse recombinant GM-
CSF (31). DCs were maintained in DMEM medium containing
10% heat-inactivated fetal bovine serum, 100 IU/ml penicillin,
100 
 
 
 
g/ml streptomycin, 2 mM 
 
l
 
-glutamine, 50 
 
 
 
-M 2-mercap-
toethanol, supplemented with 30% culture supernatant of Ag8653
that contained 10–20 mg/ml of GM-CSF. DCs were incubated
for 20 h with uninfected or 
 
P. yoelii
 
–infected erythrocytes at a
1:100 ratio (DCs/erythrocytes). Maturation of DCs was induced
20 h later with 1 
 
 
 
g/ml 
 
Salmonella enterica
 
 LPS (Sigma-Aldrich)
for 24 h. Erythrocytes were lysed before DC transfer into mice or
phenotypic characterization by FACS
 
® 
 
analysis.
 
Isolation of DCs from Mice.
 
CD11c
 
  
 
DCs were purified from
the spleens of malaria-infected and noninfected mice using anti-
CD11c antibodies bound to magnetic beads (Miltenyi Biotec).
Isolated CD11c
 
  
 
DCs were incubated with or without 1 
 
 
 
g/ml
LPS for 24 h before FACS
 
® 
 
analysis.
 
Monoclonal Antibodies and Flow Cytometry.
 
DCs were analyzed
as previously described (32) with the following antibodies: PE
anti-CD11c (HL3), FITC anti-CD40 (3/23), FITC anti-CD80
(16-10A1), FITC anti-CD86 (GL1), FITC anti–class II MHC
(39-10-8), and FITC anti–class I MHC (SF1-1.1; all from BD
Biosciences). Anti-CD16/CD32 (Fc
 
  
 
III/II receptor; 2.4G2) was
used to prevent the binding of antibodies to Fc receptors (BD
Biosciences). Cell preparations were analyzed on a FACSCalibur
 
®
 
(Becton Dickinson).
 
Transfer of DCs Incubated with Uninfected or P. yoelii–infected
Erythrocytes.
 
Bone marrow–derived DCs were incubated with
uninfected or 
 
P. yoelii
 
–infected erythrocytes and maturated withT
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LPS as described above. Erythrocytes were lysed and 5 
 
  
 
10
 
5
 
DCs were irradiated (
 
  
 
irradiation, 20 Krad) and injected intrave-
nously into BALB/c mice immunized with irradiated sporozoites
7 d before. The same number of irradiated 
 
P. yoelii
 
–infected
erythrocytes were transferred as control. ELISPOT assays were
performed 7 d after injection.
 
Macropinocytosis and Phagocytosis.
 
Macropinocytosis was quanti-
fied after incubation of bone marrow–derived DCs with 1 mg/ml
FITC-dextran (40 kD; Molecular Probes) for 2 h at 4 and 37
 
 
 
C.
FACS
 
® 
 
analysis of CD11c
 
  
 
cells was performed. DCs were also
analyzed using fluorescence microscopy. Phagocytosis was quan-
tified after incubation of DCs with ethidium bromide–labeled 
 
P.
yoelii
 
–infected erythrocytes (1:100) and fluorescence-labeled latex
beads (1:5; unpublished data) for 2 h at 4 and 37
 
 
 
C. To confirm
that infected erythrocytes were phagocytosed by DCs and not
only attached to the cell membrane, DCs were labeled with Cell
Tracker green (Molecular Probes) before incubation with ethid-
ium bromide–labeled 
 
P. yoelii
 
–infected erythrocytes.
 
Quantification of IL-10 and IL-12p70 in DC Incubation Medium
and in Mice Sera.
 
Incubation media from bone marrow–derived
DC cultures were collected 24 h after the addition or not of LPS.
Sera from heparinized blood collected from mice was obtained
by centrifugation at 2,000 
 
g
 
. The concentrations of IL-10 and IL-
12-p70 were determined by ELISA (R&D Systems).
 
Results
 
Plasmodium Blood Stage Infection Suppresses CD8
 
  
 
T Cell
Responses Against the Liver Stage of the Parasite.
 
To investi-
gate the cause of the apparent lack of CD8
 
  
 
T cell re-
sponses in malaria infections, we injected groups of BALB/c
mice with 
 
P. yoelii
 
–irradiated or nonirradiated sporozoites,
or a mixture of both. CD8
 
  
 
T cell responses against an
epitope of the CS protein of 
 
P. yoelii
 
 (29) were determined
for each mouse 10 d after injection. Irradiated sporozoites
induced a significant CD8
 
  
 
T cell response, whereas the
same number of nonirradiated sporozoites did not (Fig. 1
a). When irradiated and nonirradiated sporozoites were in-
jected together, a CD8
 
  
 
T cell response was not found
(Fig. 1 a), suggesting that nonirradiated sporozoites inhibit
the response induced by irradiated ones.
Both irradiated and nonirradiated sporozoites start a liver
infection in the host, but irradiated sporozoites fail to
progress into blood stage parasites (33). To determine
whether the blood stage of the parasite is the cause for the
observed lack of CD8
 
  
 
T cell response in normal infec-
tions, we immunized groups of mice with 
 
P. yoelii
 
–irradi-
ated sporozoites 10 d before inducing a blood stage infec-
tion by the transfer of 
 
P. yoelii
 
–infected erythrocytes. We
observed that blood stage infection inhibited the previously
established CD8
 
  
 
T cell response induced by irradiated
sporozoites (Fig. 1 b), indicating that blood stage malaria
suppresses previously established CD8  T cell responses
against a liver stage antigen.
Infections with sporozoites of the rodent malaria parasite
Plasmodium berghei induce a protective response against the
liver stage when blood stage development is inhibited by
treatment with specific drugs (34, 35). We wanted to dif-
ferentiate whether natural malaria infections do not induce
a CD8  T cell response against liver stage antigens or this
response is induced but is suppressed by the subsequent
blood stage infection. Groups of mice were treated with a
specific blood stage drug after infection with sporozoites to
allow the development a liver stage–specific immune re-
sponse while eliminating the potentially suppressive blood
stage of the disease. When blood stage parasites were elimi-
nated, a specific CD8  T cell response against a liver stage
antigen was observed (Fig. 1 c). These results indicate that
natural malaria infections generate CD8  T cells specific for
liver stage antigens that are suppressed when the disease
progresses into the blood stage.
Mice infected with blood stage P. yoelii are not able to
initiate a CD8  T cell response when immunized with irra-
diated sporozoites (Fig. 1 d). Responses could not be initi-
ated 1 mo after infection, even though the level of parasites
in the blood at this time is very low (parasitemia ranged
from 0.4 to 0.6%). The capacity to initiate immune re-
sponses is restored 2 mo after infection. Taken together,
these results indicate that malaria blood stage infection not
only suppresses existing CD8  T cell immune responses
but also inhibits the initiation of new ones.
Plasmodium-infected Erythrocytes Inhibit the Maturation of DCs
In Vitro and In Vivo. To investigate the role of DCs in blood
stage suppression of liver stage responses, we first examined
Figure 1. Liver stage Plasmodium infection induces CD8  T cell re-
sponses that are suppressed by blood stage parasites. ELISPOT results
show IFN- –secreting CD8  T cells specific for the CD8  T cell P. yoelii
CS epitope detected in the spleens of two mice. Results are expressed as
average   standard deviations for duplicates cultures. (a) Mice were immu-
nized with 105 P. yoelii–irradiated sporozoites, 105 nonirradiated sporozo-
ites, or a mixture of both. (b) Mice were immunized with 105 irradiated
sporozoites followed by 4   106 P. yoelii–infected erythrocytes (iRBC) 7 d
after immunization. (c) Mice were immunized with 105 irradiated or
105 nonirradiated sporozoites followed or not by treatment with artemisi-
nin. *, significant difference (P   0.01) in numbers of IFN-  spots com-
pared with aremisinin-treated group. (d) Mice were infected or not with
4   106 P. yoelii–infected erythrocytes (iRBC), followed by immuniza-
tion with 105 irradiated sporozoites at different times after infection. Re-
sults are expressed as percentage inhibition of IFN- –secreting CD8  T
cells as compared with noninfected immunized mice.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
146 Malaria-induced Immunosuppression by Dendritic Cells
whether P. yoelii could be used as a model for the modula-
tion of DC maturation induced by erythrocytes infected
with P. falciparum (25). Immature, bone marrow–derived
mouse DCs increase the surface expression of T cell co-
stimulatory and MHC molecules upon the addition of a
maturation stimulus such as bacterial LPS (32). Preincuba-
tion of these DCs with P. yoelii–infected erythrocytes, but
not with uninfected erythrocytes, prevents the increase of
these surface molecules in response to LPS (Fig. 2 a), con-
firming the results obtained for P. falciparum–infected
erythrocytes. This suggests that P. yoelii blood stage infec-
tion might be used as a model for the human P. falciparum,
opening the possibility of in vivo experiments that are only
feasible using animal models.
To investigate whether blood stage P. yoelii infection
inhibits the maturation of DCs during malaria infections in
vivo, we isolated DCs from the spleen of uninfected or
blood stage malaria-infected mice. As previously described
(36), we found that freshly isolated DCs from control mice
already show a partially mature phenotype, as the purifica-
tion process activates the maturation of these cells. The
addition of LPS to these cells resulted in a fully mature
phenotype (Fig. 2 b). In marked contrast, DCs obtained
from mice infected with blood stage P. yoelii showed a sig-
nificantly smaller up-regulation in the surface expression
of T cell costimulatory and MHC molecules, even after
the addition of LPS (Fig. 2 b). These results indicate that
blood stage malaria infection inhibits the maturation ca-
pacity of DCs.
Plasmodium-infected Erythrocytes Affect DC Survival and Se-
cretion of IL-12 and IL-10. DCs in vitro die within 48 h
after the addition of a maturation stimulus (30). We ob-
served that DCs preincubated with P. yoelii–infected eryth-
rocytes, but not with uninfected erythrocytes, do not die in
response to LPS stimulation (Fig. 3 a), confirming that
these DCs are not able to mature. This also suggests that
malaria blood stage infection may prolong the half-life of
DCs in this atypical state.
Figure 2. P. yoelii–infected erythrocytes inhibit the expression of co-
stimulatory and MHC molecules on DCs in vitro and in vivo. (a) Ex-
pression of costimulatory and MHC molecules on DCs alone (black bars),
preincubated with uninfected erythrocytes (gray bars) or P. yoelii–infected
erythrocytes (white bars) 24 h after the addition or not of LPS. Results are
expressed as mean fluorescence intensity as determined by FACS® analysis
of gated CD11c  cells. Error bars indicate standard deviation of dupli-
cated samples. Significant difference (*, P   0.05; **, P   0.01) in surface
expression compared with expression on DCs preincubated with unin-
fected erythrocytes. Representative results from one of four independent
experiments are shown. (b) Expression of MHC and costimulatory mole-
cules on DCs isolated from the spleens of mice 7 d after infection with 4  
106 P. yoelii–infected erythrocytes (iRBC, white bars) and uninfected
mice (black bars) 24 h after the addition or not of LPS. Representative re-
sults from one of three independent experiments are shown. Error bars
indicate standard deviation of duplicated samples. Significant difference (*,
P   0.05; **, P   0.01) in surface expression compared with expression
on DCs from uninfected mice.
Figure 3. P. yoelii-infected erythrocytes prevent DC death and reverse
the IL-12/IL-10 secretion pattern. (a) Percentage of survival of DCs
(FACS® analysis of CD11c , propidium iodide ) alone ( ), preincubated
with uninfected erythrocytes ( ), or with P. yoelii–infected erythrocytes
( ) after the addition of LPS. (b) Concentration of IL-12p70 (top) and
IL-10 (bottom) secreted by DCs alone, preincubated with uninfected
erythrocytes (RBC), or P. yoelii–infected erythrocytes (iRBC) after the
addition (black bars) or not (white bars) of LPS. Representative results
from one of three independent experiments are shown. Error bars indicate
standard deviation of duplicated samples. Concentration of (c) IL-12p70
and (d) IL-10 in sera of malaria-infected mice. Sera were obtained from
heparinized blood at different time points after infection with 4   106 P.
yoelii–infected erythrocytes. Representative results from one of three mice
are shown. Error bars indicate standard deviation of duplicated samples.T
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IL-12 secreted by mature DCs is an important factor to
initiate a cellular immune response. IL-10, on the other
hand, has a suppressive effect on both DC maturation and
cellular immune responses and can also be secreted by DCs
(23). We found that the preincubation of DCs with P.
yoelii–infected erythrocytes inhibits the secretion of IL-12
in response to a maturation stimulus such as LPS. Con-
versely, the secretion of IL-10 by DCs was increased under
these conditions (Fig. 3 b). Interestingly, this pattern in the
levels of the cytokines is also observed in vivo after the in-
fection of mice with blood stage P. yoelii (Fig. 3, c and d).
Plasmodium-infected Erythrocytes Do Not Interfere with Anti-
gen Internalization, but Inhibit Antigen-specific CD8  T Cell
Activation by DCs. Immature DCs efficiently internalize
exogenous antigens to use for antigen presentation associ-
ated with MHC class I and II molecules (23). We investi-
gated the effect of P. yoelii–infected erythrocytes on DC
macropinocytosis and phagocytosis, the two principal
mechanisms DCs use to internalize exogenous antigens.
DCs alone or preincubated with normal or P. yoelii–infected
erythrocytes did not show any differences in their macropi-
nocytic (Fig. 4, a and c) or phagocytic capacity (Fig. 4, b
and d), indicating that these mechanisms of antigen up-take
are not affected. We observed that P. yoelii–infected eryth-
rocytes (Fig. 4 d) and fluorescent latex beads (not depicted)
are efficiently phagocytosed by DCs preincubated or not
with P. yoelii–infected erythrocytes.
DCs are potent stimulators of naive and memory T cells
(23). To investigate whether deficient T cell activation by
DCs may play a role in the lack of CD8  T cell responses
against Plasmodium liver stage antigens, we studied the ca-
pacity of DCs incubated with uninfected or P. yoelii–
infected erythrocytes to activate CD8  T cells from a cloned
line specific for a liver stage P. yoelii epitope (29). DCs
were incubated with a peptide spanning the CD8 epitope
or infected with a recombinant influenza virus expressing
the same epitope (28). Preincubation of DCs with P. yoelii–
infected erythrocytes inhibited antigen-specific T cell acti-
vation, measured as the capacity of CD8  T cell clone to
secrete IFN-  (Fig. 5, a and b) and proliferate (Fig. 5 c).
Similar results were observed after the addition of LPS to
the cocultures (not depicted). We also found that P. yoelii
sporozoites, as opposed to infected erythrocytes, do not in-
hibit DC activation of T cells (not depicted).
To determine whether DCs from blood stage Plasmo-
dium-infected mice also suppress CD8  T cell responses,
we isolated DCs from uninfected or infected mice and de-
termined their capacity to activate the CD8  T cell clone.
We found that the activation of cells from the CD8  T cell
clone is inhibited in DCs from infected mice (Fig. 5 d).
We wanted to distinguish whether the observed lack of
activation of CD8  T cells is due to deficient antigen pre-
sentation by DCs or to an inhibitory effect on the T cells.
Incubation medium from bone marrow–derived DCs and
uninfected or P. yoelii–infected erythrocytes with or with-
out LPS, was added to DCs or A20.2J B cell lymphoma
cells loaded with the CD8-specific epitope. T cells from
the specific CD8  T cell clone were added and activation
was measured as secretion of IFN-  by T cells. We ob-
served that the presence of incubation medium from DCs
and P. yoelii–infected erythrocytes inhibited the activation
of specific T cells by A20.2J cells or DCs (Fig. 5, e and f).
This inhibitory activity was not dependent on the presence
of LPS in the DCs/erythrocytes cocultures. These results
indicate that CD8  T cell activation is inhibited by soluble
factors secreted by DC/P. yoelii–infected erythrocytes co-
cultures. These factors are probably secreted by DCs, as the
inhibitory activity was not found in the incubation me-
dium of infected erythrocytes alone (not depicted). A re-
duced inhibition (22%) of T cell activation was also ob-
served in the presence of supernatants from DCs isolated
from infected mice when compared with supernatants from
cells of uninfected mice (not depicted).
We wanted to determine whether the reduced secretion
of IL-12 or the increased secretion of IL-10 induced in DCs
by P. yoelii–infected erythrocytes mediate the inhibitory ac-
tivity on T cells. The addition of exogenous IL-12 or
blocking antibodies against IL-10 did not interfere with the
inhibition of T cell activation by DCs, suggesting that these
cytokines do not mediate the inhibitory effect (Fig. 5 g).
DCs Incubated with Plasmodium-infected Erythrocytes Sup-
press Protective CD8  T Cell Responses Against Liver Stage
Malaria. We found that after incubation with DCs prein-
cubated with P. yoelii–infected erythrocytes, CD8  T cells
are not responsive to antigen presentation (Fig. 6 a). We
Figure 4. P. yoelii–infected erythrocytes do not affect antigen uptake
by DCs. (a) Macropinocytosis of FITC-dextran and (b) phagocytosis of
ethidium bromide–labeled P. yoelii–infected erythrocytes by DCs alone,
preincubated with uninfected erythrocytes (RBC) or with P. yoelii–
infected erythrocytes (iRBC). DCs were incubated for 2 h with FITC-
dextran at 4 C (filled histogram) or 37 C (solid line). Histograms show
CD11c  gated cells. (c) DCs after incubation with FITC-dextran at 37 C.
Fluorescence shows dextran internalization and no staining was observed
after incubation at 4 C (not depicted). (d) DCs labeled with Cell Tracker
(green) after phagocytosis of a P. yoelii–infected erythrocyte labeled with
ethidium bromide (red).T
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wanted to investigate whether DCs also inhibit CD8  T
cell activation as a consequence of blood stage infection in
vivo. DCs preincubated with uninfected or P. yoelii–infected
erythrocytes were transferred into mice immunized with
irradiated P. yoelii sporozoites. To avoid infection of mice
with infected erythrocytes from the cocultures, erythro-
cytes were lysed and cultures were irradiated before in-
jection into mice. We found that mice injected with
DCs preincubated with P. yoelii–infected erythrocytes
Figure 5. Blood stage infection induces DCs to secrete soluble factors
that inhibit the activation of CD8  T cells. Results of ELISPOT showing
IFN- –secreting cells from the CD8  T cell clone specific for P. yoelii CS
epitope. Bone marrow–derived DCs preincubated with uninfected eryth-
rocytes (RBC) or P. yoelii–infected erythrocytes (iRBC) were incubated
with a peptide spanning the (a) CS CD8 epitope or (b) recombinant in-
fluenza virus expressing the same epitope before the addition of clone
cells. As control, DCs without peptide or virus were incubated with
clone cells. Representative results from one of three independent experi-
ments are shown. (c) Proliferation of CFDA SE–stained CD8  T cell
clone cells after 5 d of incubation with DCs pulsed with the CD8 epitope
peptide and preincubated with uninfected erythrocytes (RBC) or P.
yoelii–infected erythrocytes (iRBC). Representative results from one of
two independent experiments are shown. (d) DCs were isolated from the
spleens of mice 7 d after infection with 4   106 P. yoelii–infected erythro-
cytes (iRBC) or noninfected mice (control) before incubation with the
CD8 epitope peptide and the addition of clone cells. Representative re-
sults from one of three mice are shown. (e and f) The incubation medium
of cocultures of DCs and uninfected or P. yoelii–infected erythrocytes was
added to (e) A20.2J cells or (f) DCs loaded with the peptide spanning the
CS epitope before the addition of clone cells. Incubation medium (IM)
from DCs and uninfected erythrocytes (IM1), DCs and uninfected eryth-
rocytes with LPS (IM2), DCs and P. yoelii–infected erythrocytes (IM3),
and DCs and P. yoelii–infected erythrocytes with LPS (IM3) are shown.
As control, DCs or A20.2J cells without peptide were incubated with
clone cells. Results are expressed as percentage inhibition of IFN- –secret-
ing cells from CD8  T cell clone incubated with each IM as compared
with those incubated with normal medium. Representative results from
one of two independent experiments are shown. (g) DCs pulsed with the
CD8 epitope and preincubated with medium (black bars), uninfected
erythrocytes (gray bars), or P. yoelii–infected erythrocytes (white bars)
were mixed with CD8  T cell clone cells in the presence of recombinant
mouse IL-12 or anti–mouse IL-10 blocking monoclonal antibody. Signif-
icant difference (*, P   0.1; **, P   0.05) in IFN-  spots compared with
DCs preincubated with uninfected erythrocytes. Error bars indicate stan-
dard deviation of duplicated samples.
Figure 6. Protective immune responses against malaria liver stage are
suppressed by the transfer of DCs incubated with P. yoelii–infected eryth-
rocytes. (a) Results of ELISPOT showing the numbers of IFN- –secret-
ing CD8  T cells from the CD8  T cell clone specific for P. yoelii CS
epitope. DCs preincubated with uninfected erythrocytes (DC   RBC)
or P. yoelii–infected erythrocytes (DC   iRBC) were incubated with
clone cells at a 2:1 ratio for 7 d before the addition of A20.2J loaded with
the peptide spanning the CD8 epitope. As control, A20.2J cells without
peptide were incubated with cocultures of DCs/clone cells. Representa-
tive results from one of two independent experiments are shown. (b) Re-
sults of ELISPOT showing the numbers of IFN- –secreting CD8  T cells
detected in the spleens of mice immunized with irradiated sporozoites
and inoculated or not (control) 7 d later with DCs preincubated with un-
infected erythrocytes (DC    RBC) or P. yoelii–infected erythrocytes
(DC   iRBC) and stimulated with LPS. Another group of mice was in-
oculated with P. yoelii–infected erythrocytes alone (iRBC). All cells were
irradiated before injection into mice to avoid the development of blood
stage malaria infection. *, significant difference (P   0.01) in IFN-  spots
compared with the other groups. ELISPOT was performed 7 d after the
transfer of DCs. (c) P. yoelii development in the livers of mice after chal-
lenge with sporozoites. Mice were immunized with irradiated sporozo-
ites, followed by inoculation 7 d later of DCs preincubated with unin-
fected erythrocytes (DC   RBC) or P. yoelii–infected erythrocytes (DC  
iRBC), and challenged 7 d later. *, significant difference (P   0.01) in the
number of RNA molecules compared with the other groups. Represen-
tative results from one of three independent experiments are shown.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
149 Ocaña-Morgner et al.
loose the CD8  T cell response previously induced by ir-
radiated sporozoites (Fig. 6 b). A control group of mice in-
jected only with irradiated P. yoelii–infected erythrocytes
did not show a decrease in the CD8  T cell response, con-
firming that the DCs and not residual infected erythro-
cytes are responsible for the suppressive effect on the T
cell response.
To determine the importance of DC-induced suppres-
sion of CD8  T cell responses in protection against a ma-
laria infection, we injected groups of mice immunized with
irradiated sporozoites with DCs preincubated with unin-
fected or P. yoelii–infected erythrocytes. Development of
P. yoelii in the liver was detected by real time PCR of Plas-
modium ribosomal RNA in the livers of infected mice (26)
after challenge with P. yoelii sporozoites. Mice receiving
DCs preincubated with P. yoelii–infected erythrocytes pre-
sented a decreased level of protection (40 times higher par-
asite development in the liver) when compared with mice
injected with DCs preincubated with normal erythrocytes
(Fig. 6 c).
Discussion
Natural malaria infections induce much lower CD8  T
cell responses against liver stage antigens than immuniza-
tion with irradiated sporozoites (3). In endemic areas, the
percentage of responder individuals and CD8  T cell pre-
cursor frequencies to liver stage malaria antigens are lower
than those observed for other infectious agents. In addition,
these T cell responses do not increase due to repeated in-
fections (3). All these suggest that the generation or main-
tenance of CD8  T cell responses might be inhibited dur-
ing natural malaria infections.
Our results show that Plasmodium infections induce liver
stage–specific CD8  T cells, but these responses are inhib-
ited during the blood stage of the disease. This evasion
strategy is likely to have a major impact in the transmission
of malaria because it confers a significant advantage to the
parasite, leaving the host unprotected for the next infec-
tion. These results may explain the lack of protective im-
munity against liver stage parasites observed in populations
living in malaria endemic areas, which results in constant
reinfections throughout life.
Plasmodium-infected erythrocytes have been proposed
as mediators of malaria-induced immune dysregulation
through the modulation of DC maturation (25). The incu-
bation of erythrocytes infected with the human parasite P.
falciparum inhibits the maturation (25) and changes the cy-
tokine secretion pattern of DCs (37) in response to LPS.
We found that P. yoelii–infected erythrocytes induce the
same in vitro responses as P. falciparum. Although another
study using the rodent malaria parasite Plasmodium chabaudi
found direct activation of DCs by infected erythrocytes in
vitro (38), it is possible that this parasite also induces the
suppression of DCs in vivo, as DCs isolated from P. cha-
baudi–infected mice fail to mature after stimulation with
LPS (39).
The use of a rodent malaria model allowed us to study
the role of DCs in malaria infections in vivo. As observed
in the in vitro assays, we found that DCs isolated from ma-
laria blood stage–infected mice are also unable to mature.
Because maturation of DCs is required for the activation of
naive T cells (23), a defect in this crucial step is likely to in-
terfere with the initiation of new antigen-specific immune
responses. This might be the cause for the inability to ini-
tiate immune responses against irradiated sporozoites that
we observed in mice for 1 mo after infection with blood
stage parasites and for the reduced responses to vaccination
observed during malaria infections (14, 15).
In addition to the inhibition of maturation and initiation
of T cell responses, we observed that DCs incubated with
P. yoelii–infected erythrocytes actively suppress T cell re-
sponses that were established before. The inhibition of
CD8  T cell responses is mediated by soluble factors that
result in the inhibition of IFN-  secretion by T cells. Dur-
ing malaria infections Plasmodium-infected erythrocytes en-
counter DCs in the blood and spleen. This interaction
would lead to the functional dysregulation of DCs and the
secretion of suppressive factors that inhibit the activation of
circulating CD8  T cells. As IFN-  secreted by CD8  T
cells mediates protection against liver stage malaria (40),
this inhibition might be the key factor mediating the lack
of protection observed in natural infections.
IL-10 suppresses multiple activities in the immune sys-
tem, including T cell activation (41). IL-10 concentrations
are increased in malaria blood stage–infected mice and hu-
mans (37, 42), and probably contribute to the generalized
immunosuppression that is observed in this stage of the
disease. We observed that activation with LPS induced an
increased secretion of this cytokine in DCs incubated with
P. yoelii–infected erythrocytes. However, the inhibition of
CD8  T cell activation that we observe in vitro cannot be
attributed to IL-10, as neutralization of IL-10 with block-
ing antibodies did not interfere with the inhibition of T
cell activation.
DCs maturation is followed by apoptotic death (23). We
observed that DCs incubated with infected erythrocytes do
not mature and also do not die in response to LPS. These
DCs, which presumably secrete suppressive factors for T
cell activation, would have a prolonged half-life in the
body, enhancing the inhibitory effect over CD8  T cells.
In fact, 1 mo after the initiation of a blood stage malaria in-
fection when the levels of circulating infected erythrocytes
are very low, we still found a profound inhibition of the
CD8  T cell response against liver stage antigens.
Impaired phagocytosis of P. falciparum–infected erythro-
cytes by DCs was observed using electron microcopy (25).
However, we found that phagocytosis and macropinocyto-
sis, two of the main mechanisms for antigen uptake in DCs,
are not altered after incubation with P. yoelii–infected
erythrocytes. Therefore, the lack of T cell activation ob-
served does not appear to be caused by deficient antigen in-
ternalization, but rather to the secretion of soluble factors
that inhibit T cell activation.T
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LPS induces the maturation of DCs through the activa-
tion of the Toll-like receptor 4, which mediates the secre-
tion of IL-12 and the up-regulation of costimulatory mole-
cules in these cells (43). Plasmodium-infected erythrocytes
presumably interfere with this signaling pathway, as DCs
response to LPS is severely altered. The lack of secretion of
IL-12 by DCs in response to LPS may explain the de-
creased levels of IL-12 observed during the blood stage of
malaria infections, as these cells are the main source of this
cytokine (44). IL-12 is not only involved in the initiation
of T cell immune responses, but is also implicated in main-
taining these responses (45). The decreased levels of IL-12
may also contribute to the disappearance of liver stage–spe-
cific CD8  T cells observed in vivo.
We conclude that DC functions that are essential for im-
mune regulation are severely affected during Plasmodium
blood stage infections. These include the inhibition of the
expression of costimulatory and MHC class I and II mole-
cules as well as the capacity to initiate new immune re-
sponses. In addition, DCs secrete soluble factors that inhibit
the activation of CD8  T cells. This probably mediates the
suppression of protective liver stage immune responses that
are induced during the initial stage of the disease.
Understanding of the evasion mechanisms of Plasmo-
dium is essential to develop effective strategies against ma-
laria. Interfering with Plasmodium-induced suppression
may lead to the establishment of effective protective im-
munity against the liver stage, opening new possibilities of
treatment and prevention. Blood stage–induced immuno-
suppression should also be considered for vaccine design,
as it reinforces the necessity of vaccinating against both
liver and blood stages. Effective immunization against liver
stage Plasmodium would overcome this suppressive strategy
by avoiding the development of blood stage parasites. Im-
munization against blood stage would also be essential to
minimize the suppressive effect of infected erythrocytes
during infection.
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